ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

SMARCC2 combined with c-Myc inhibits the migration and invasion of glioma cells via modulation of the Wnt/β-catenin signaling pathway

Li, Chiyang; Fei, Chengshuo; Li, Junjie; Wu, Hang; Chen, Lei; Roshani, Ramzi; Li, Hong; Shi, Linyong; Song, Chong; Gu, Junwei; Lu, Yuntao*; Zhou, Qiang*南方医科大学
Molecular Medicine Reports2021-8DOI: 10.3892/mmr.2021.12190
3被引6阅读
引用收藏
分享

摘要

Glioma is the most common type of central nervous system tumor. SWItch/sucrose non-fermentable (SWI/SNF) is a tumor suppressor that serves an important role in epithelial-mesenchymal transition (EMT). The present study aimed to identify key molecules involved in the EMT process. SWI/SNF related, matrix associated, actin dependent regulator of chromatin subfamily c member 2 (SMARCC2) is mutated in and its expression is low in multiple types of cancer. SMARCC2 is the core subunit of the chromatin-remodeling complex, SWI/SNF. Relative mRNA SMARCC2 expression levels in human glioma tissue were analyzed via reverse transcription-quantitative PCR, whereas the protein expression levels were determined via immunohistochemistry staining. SMARCC2 expression was knocked down in glioma cells using small interfering RNA (si) and overexpressed by infection with adenovirus vectors carrying SMARCC2 cDNA. Wound healing and Transwell assays were performed to assess cell migration and invasion, respectively. Subsequently, immunofluorescence and western blotting were performed to analyze the expression levels of the oncogene c-Myc, which is associated with SMARCC2. SMARCC2 combines with C-MYC to downregulate its expression. Consistent with the results of the bioinformatics analysis, which revealed that the upregulated expression levels of SMARCC2 were associated with a more favorable prognosis in patients with glioma, the mRNA and protein expression levels of SMARCC2 were significantly upregulated in low-grade glioma tissues compared with high-grade glioma tissues. The results of the wound healing assay demonstrated that cell migration was significantly increased in the siSMARCC2-1/3 groups compared with the negative control (NC) group. By contrast, the migratory ability of cells was significantly reduced following transduction with adenovirus overexpressing SMARCC2, which upregulated the expression of SMARCC2, compared with the lentiviral vector-non-specific control (LVS-NC) group. The Transwell assay results further showed that SMARCC2 overexpression significantly inhibited the migratory and invasive abilities of U87MG and LN229 cells compared with the LVS-NC group. Co-immunoprecipitation assays were subsequently conducted to validate the binding of SMARCC2 and c-Myc; the results demonstrated that the expression of c-Myc was downregulated in adenovirus-transfected cells compared with LVS-NC-transfected cells. The results of the western blotting experiments demonstrated that the expression levels of N-cadherin, vimentin, snail family transcriptional repressor 1 and beta-catenin were notably downregulated, whereas the expression levels of T-cadherin were markedly upregulated in cell lines stably overexpressing SMARCC2 compared with the LVS-NC group. In conclusion, the results of the present study suggested that SMARCC2 may inhibit Wnt/beta-catenin signaling by regulating c-Myc expression in glioma. SMARCC2 regulates the EMT status of the glioblastoma cell line by mediating the expression of the oncogene C-MYC to inhibit its migration and invasion ability. Thus, SMARCC2 may function as a tumor suppressor or oncogene by regulating associated oncogenes or tumor suppressor genes.

学科与关键词

关键词
SWItchsucrose non-fermentableSWISNF relatedmatrix associatedactin dependent regulator of chromatin subfamily c member 2c-Mycepithelial-mesenchymal transitionglioma
相关
加载中…
  • SMARCC2 mediates the regulation of DKK1 by the transcription factor EGR1 through chromatin remodeling to reduce the proliferative capacity of glioblastoma
    Li, Chiyang; Wang, Tong; Gu, Junwei; Qi, Songtao; Li, Junjie; Chen, Lei; Wu, Hang; Shi, Linyong; Song, Chong; Li, Hong; Zhu, Liwen; Lu, Yuntao; Zhou, Qiang*Cell Death & Disease, 2022, 13(11): 990.被引 3
  • SMARCC1 Suppresses Tumor Progression by Inhibiting the PI3K/AKT Signaling Pathway in Prostate Cancer
    Xiao, Zhao-Ming; Lv, Dao-Jun; Yu, Yu-Zhong; Wang, Chong; Xie, Tao; Wang, Tao; Song, Xian-Lu; Zhao, Shan-Chao*Frontiers in Cell and Developmental Biology, 2021, 9: 678967.被引 9
  • SMARCC2 mediates the regulation of DKK1 by the transcription factor EGR1 through chromatin remodeling to reduce the proliferative capacity of glioblastoma (vol 13, 990, 2022)
    Li, Chiyang; Wang, Tong; Gu, Junwei; Qi, Songtao; Li, Junjie; Chen, Lei; Wu, Hang; Shi, Linyong; Song, Chong; Li, Hong; Zhu, Liwen; Lu, Yuntao*; Zhou, Qiang*Cell Death & Disease, 2023, 14(7): 411.
查看全部 →

发表信息

论文状态
公开发表
期刊
Molecular Medicine Reports
发表日期
2021-08
卷期
第 24 卷, 第 2 期
页码
551
DOI
10.3892/mmr.2021.12190
语言
ENGLISH
期刊收录
NSL
期刊等级
4区
成果收录
SCIE
资助标注
National Natural Science Foundation of China [81802830]

作者

  • L

    Li, Chiyang (第一作者)

    southern med univ

  • F

    Fei, Chengshuo

    southern med univ

查看全部 12 位作者收起作者
  • L

    Li, Junjie

    southern med univ

  • W

    Wu, Hang

    southern med univ

  • C

    Chen, Lei

    southern med univ

  • R

    Roshani, Ramzi

    southern med univ

  • L

    Li, Hong

    southern med univ

  • S

    Shi, Linyong

    southern med univ

  • S

    Song, Chong

    southern med univ

  • G

    Gu, Junwei

    southern med univ

  • L

    Lu, Yuntao (通讯)

    southern med univ

  • Z

    Zhou, Qiang (通讯)

    southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417